Separation and estimation of process related impurities and degradation products of levetiracetam in solid pharmaceutical formulation using ion-pair chromatography

Journal of Liquid Chromatography and Related Technologies

Volumn 36, Issue 13, 2013, Pages 1835-1848

  Kumar, Navneet ^a,b   Sangeetha, D ^b  

^a DR REDDY'S LABORATORIES LTD   (India)

^b VIT UNIVERSITY   (India)

Author keywords

Development; Forced degradation; HPLC UV; Impurities; Levetiracetam; Validation

Indexed keywords

DEVELOPMENT; FORCED DEGRADATION; HPLC-UV; LEVETIRACETAM; VALIDATION;

CHROMATOGRAPHIC ANALYSIS; DEGRADATION; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIGH PRESSURE LIQUID CHROMATOGRAPHY; HYDROLYSIS; IMPURITIES;

CHROMATOGRAPHY;

ETIRACETAM;

ARTICLE; CHEMICAL STRESS; DRUG DEGRADATION; DRUG HYDROLYSIS; DRUG IMPURITY; DRUG OXIDATION; DRUG STABILITY; FLOW RATE; ION PAIR CHROMATOGRAPHY; LIMIT OF DETECTION; LIMIT OF QUANTITATION; MEASUREMENT ACCURACY; OXIDATIVE STRESS; PH; PHASE SEPARATION; PHOTOLYSIS; SENSITIVITY AND SPECIFICITY; SOLID; TABLET FORMULATION; THERMAL ANALYSIS; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

EID: 84877973862     PISSN: 10826076     EISSN: 1520572X     Source Type: Journal    
DOI: 10.1080/10826076.2012.704606     Document Type: Article

References (18)

1. U. S. Food and Drug Administration. Drug Approval Package Keppra (Levetiracetam) Tablets NDA 21035, 1999.http://www.accessdata.fda.gov/ drugsatfda-docs/nda/99/21035-Keppra.cfm (Accessed March 2011)
2. www.Rxlist.com/cgi/generic3/keppra.htm
3. Reddy, T. S.; Devi, P. S. Validation of a High-Performance Thin-Layer Chromatographic Method with Densitometric Detection for Quantitative Analysis of Two Anticonvulsants in Tablets. J. Plan. Chromatogr. 2007, 20, 451-456.
4. Ivanova, M.; Piunti, A.; Marziali, E.; Komarova, N.; Raggi, M. A.; Kenndler, E. Microemulsion Electrokinetic Chromatography Applied for Separation of Levetiracetam from Other Antiepileptic Drugs in Polypharmacy. Electrophoresis. 2003, 24, 992-998.
5. Shihabi, Z. K.; Oles, K.; Hinsdale, M. Analysis of the Antiepileptic Drug Keppra by Capillary Electrophoresis. J. Chromatogr A. 2003, 1004, 9-12.
6. Martens-Lobenhoffer, J.; Bode-Boger, S. M. Determination of Levetiracetam in Human Plasma with Minimal Sample Pretreatment. J. Chromatogr. B. 2005, 819, 197-200.
7. Matar, K. M. Quantification of Levetircetam in Human Plasma by Liquid Chromatrography-Tandem Mass Spectroscopy: Application to Therapeutic Drug Monitoring. J. Pharm. Biomed. Anal. 2008, 48, 822-828.
8. Jain, D. S.; Subbaiah, G.; Sanyal, M.; Pal, U.; Shrivastav, P. S. Determination of Levetiracetam in Human Plasma by Liquid Chromatography= Electrospray Tandem Mass Spectrometer and Its Application to Bioequivalence Studies. Rapid Commun. Mass Spectrom. 2006, 20, 2539-2547.
9. Contin, M.; Mohamed, S.; Albani, F.; Riva, R.; Baruzzi, A. Simple and Validated HPLC- UVAnalysis of Levetiracetam in Deproteinized Plasma of Patients with Epilepsy. J. Chromatogr. B. 2008, 873, 129-132.
10. Can, N. O.; Arli, G. Reversed-Phase HPLC Analysis of Levetiracetam in Tablets Using Monolithic and Conventional C18 Silica Columns. J. AOAC Internat. 2010, 93, 1-9.
11. Valarmathy, J.; Samueljoshua, L.; Rathinavel, G.; Thanuja, C. S.; Sivakumar, T. RP-HPLC Method Development and Validation for Assay of Levetiracetam in Tablet Dosage Form. Research J. Pharm.and Tech. 2008, 1, 395-397.
12. Appala, R. N.; Rao, J. V.; Prakash, K. V.; Mukkanti, K.; Srinivasu, K. Estimation of Levetiracetam in Tablet Dosage Form by RP-HPLC. E-J. Chem. 2008, 5, 1098-1102.
13. Rao, B. M.; Rai, R.; Reddy, B. S. S.; Sivakumar, S.; Chand, I. G.; Kumar, K. P.; Acharyulu, P. V. R.; Reddy, G. O.; Srinivasu, M. K. A Validated Chiral LC Method for the Enantioselective Analysis of Levetiracetam and Its Enantiomer R-a-ethyl-2-oxo-pyrrolidine Acetamide on Amylase-Based Stationary Phase. J. Pharm. Biomed. Anal. 2004, 35, 1017-1026.
14. U. S. Pharmacopeia. 32nd Ed., U. S. Pharmacopeial Convention, Rockville, MD, 2010.
15. European Pharmacopeia, 7th Ed., European Directorate for Quality of Medicines, France, 2010.
16. International Conference on Harmonization. (ICH) Q1A (R2), Stability Testing of New Drug Substances and Products, 2003, Geneva.
17. International Conference on Harmonization. (ICH) Q1B, Photostability testing on new drug substances and products, 1996, Geneva.
18. International Conference on Harmonization. (ICH) Q2 (R1), Validation of Analytical Procedures: Text and Methodology, 2005, Geneva.